(photo by Taiwan RedEye Biomedical Inc.)

    Colorectal cancer has ranked first in Taiwan for 11 consecutive years. In order to discover the problem of occult blood earlier, a domestic startup company, Taiwan RedEye Biomedical Inc., has developed photoelectric blood detecting technology. They use the optical principle to determine the various signals in the toilet water, including every kind of Impurities, and then analyze it. Eventually, getting the results that if there is blood in it. The technology also won 2019 National Innovation Award recently.

Nelson Yan, the founder of Taiwan RedEye Biomedical Inc., said that, although we can’t prevent the occurrence of the disease, we still have the chance to help people find the symptoms of the disease and do the treatment earlier. RedEye’s technology and products have passed the three-stage examination and are confirmed that they have the innovation advantage, R&D power, and developing potentiality. Finally, RedEye won the 16th National Innovation Award.

Taiwan RedEye Biomedical Inc. has permitted to be station in Hsinchu Science Park. The company’s first photoelectric blood detecting sensor belongs to the field of Bio-ICT. It can be applied to detect if there is trace of blood in turbid water at home. It provides the functions of pre-warning and offers the outcomes of pre-screening at home to the hospital.

Taiwan RedEye Biomedical Inc. pointed out that this home-used health monitoring product belongs to photoelectric detection apparatus. It uses the optical principle to determine the various signals in the toilet water, including every kind of Impurities, and then analyze it. Eventually, getting the results that if there is blood in it.

Besides, the plan of RedEye’s product lines is diverse. The hemoglobin sensor can not only be mounted on the wall or put it on the table outside of the bathroom, but also the technology can be combined with the washlet for people to detect right after excreting.

Nelson Yan said that, take Taiwan as the example, there are about one-third of patients diagnosed with colorectal cancer each year are in the third and fourth stages. The rate is quite high. He hopes that there will be the chance for people to find the symptoms on the first or second stage and go to the hospital for re-examination. If people can do the treatment earlier, the survival rate in five years can still be high.

(source: Commercial Times, Yong-Cheng, Chen / Taipei)